Hey gang, I still consider myself pretty green to investing and figuring out when to sell is the hardest part for me still. I've had some bulls eyes and I've had some blunders!
The one I'm currently debating on is ABEO I bought back in October when they submitted for a FDA approval for treatment of a rare connective tissue disorder. My thesis was I figured they would get approval which they just did. This is my first time investing in anything with that strategy and so now I'm looking at +20% gains atm but it's still some where around 10% below it's 52wk high in June.. Should I be happy with the 20%? What is your typical exit strategy in these fda approval situations? TIA
Leave a Reply